Methods of treating an IL-17A mediated pathological condition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9890219
SERIAL NO

14706234

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB BIOPHARMA SPRL60 ALLEE DE LA RECHERCHE BRUSSELS B-1070

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adams, Ralph Berkshire, GB 62 364
Popplewell, Andrew George Berkshire, GB 51 584
Rapecki, Stephen Edward Berkshire, GB 46 270

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00